Physician Perceptions About Generic Drugs
暂无分享,去创建一个
William H Shrank | T. Brennan | J. Liberman | M. Fischer | W. Shrank | N. Choudhry | Troyen A Brennan | Niteesh K Choudhry | Joshua N Liberman | Michael A Fischer | Charmaine Girdish | Charmaine Girdish
[1] K. Tomaszewski,et al. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy , 2005, Epilepsy & Behavior.
[2] Riyaj Shamsudeen. Do Not Use , 2011 .
[3] A. Kesselheim,et al. Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs , 2010, Drugs.
[4] L. Casalino,et al. Patient-physician communication about out-of-pocket costs. , 2003, JAMA.
[5] J. Kersnik,et al. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies , 2006, Journal of clinical pharmacy and therapeutics.
[6] Susan L Ettner,et al. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. , 2006, Archives of internal medicine.
[7] J. Douketis,et al. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. , 2005, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[8] W. Bearden,et al. Generic Drugs: Consumer, Pharmacist and Physician Perceptions of the Issues , 1980 .
[9] William H Shrank,et al. Patients' perceptions of generic medications. , 2009, Health affairs.
[10] R. Gross,et al. Generic substitution in the treatment of epilepsy: Patient and physician perceptions , 2008, Epilepsy & Behavior.
[11] M. Gossell-Williams. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. , 2007, The West Indian medical journal.
[12] B. Banahan,et al. A physician survey on generic drugs and substitution of critical dose medications. , 1997, Archives of internal medicine.
[13] J. Avorn,et al. Economic implications of evidence-based prescribing for hypertension: can better care cost less? , 2004, JAMA.
[14] M Alan Brookhart,et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. , 2008, JAMA.
[15] Kathryn A Phillips,et al. Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 19972000 , 2005, Annals of Internal Medicine.
[16] G. Alexander,et al. 1 CHARACTERISTICS OF PATIENTS RECEIVING PHARMACEUTICAL SAMPLES AND ASSOCIATION BETWEEN SAMPLE RECEIPT AND OUT-OF-POCKET PRESCRIPTION COSTS. , 2007, Journal of Investigative Medicine.
[17] W. Shrank,et al. Increasing Generic Drug Use in Medicare Part D: The Role of Government , 2007, Journal of the American Geriatrics Society.
[18] Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. , 2009, American heart journal.
[19] Lawrence X. Yu,et al. Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration , 2009, The Annals of pharmacotherapy.
[20] A. Awaisu,et al. Physicians' Views on Generic Medicines: A Narrative Review , 2010 .
[21] Richard L Kravitz,et al. Physician communication about the cost and acquisition of newly prescribed medications. , 2006, The American journal of managed care.
[22] Barbara M Rothenberg,et al. Impact of alternative interventions on changes in generic dispensing rates. , 2006, Health services research.
[23] J. Kyriopoulos,et al. Generic medicines: Greek physicians’ perceptions and prescribing practices , 2009, Journal of clinical pharmacy and therapeutics.